Nexalin Technology, Inc.(NXL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NXL Nexalin Technology, Inc.

盘后交易 04-16 17:53:24 EDT

0.4645

-0.0445

-8.74%

盘后0.4500

-0.0145-3.12%

17:16 EDT

最高0.5000	最低0.4500	成交量22.70万
今开0.5000	昨收0.5090	日振幅9.82%
总市值956.02万	流通市值829.65万	总股本2,058万
成交额10.66万	换手率1.27%	流通股本1,786万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NXL","market":"US","secType":"STK","nameCN":"Nexalin Technology, Inc.","latestPrice":0.4645,"timestamp":1776369600000,"preClose":0.509,"halted":0,"volume":226993,"hourTrading":{"tag":"盘后","latestPrice":0.45,"preClose":0.4645,"latestTime":"17:16 EDT","volume":11392,"amount":5151.3872128,"timestamp":1776374200654,"change":-0.0145,"changeRate":-0.031216,"amplitude":0.043057},"delay":0,"changeRate":-0.08742632612966598,"floatShares":17861200,"shares":20581600,"eps":-0.501582,"marketStatus":"盘后交易","change":-0.0445,"latestTime":"04-16 17:53:24 EDT","open":0.5,"high":0.5,"low":0.45,"amount":106585.20781012,"amplitude":0.098232,"askPrice":0.48,"askSize":2000,"bidPrice":0.45,"bidSize":60,"shortable":0,"etf":0,"ttmEps":-0.501582,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1776384000000},"marketStatusCode":4,"adr":0,"listingDate":1663300800000,"exchange":"NASDAQ","adjPreClose":0.509,"preHourTrading":{"tag":"盘前","latestPrice":0.4864,"preClose":0.509,"latestTime":"08:55 EDT","volume":9562,"amount":4650.626911,"timestamp":1776344156777,"change":-0.0226,"changeRate":-0.044401,"amplitude":0.037721},"postHourTrading":{"tag":"盘后","latestPrice":0.45,"preClose":0.4645,"latestTime":"17:16 EDT","volume":11392,"amount":5151.3872128,"timestamp":1776374200654,"change":-0.0145,"changeRate":-0.031216,"amplitude":0.043057},"volumeRatio":0.059913},"requestUrl":"/m/hq/s/NXL","defaultTab":"news","newsList":[{"id":"1110992916","title":"Nexalin Technology Inc. 计划于2026年第二季度根据战略会议提交修订版FDA Q-Submission申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1110992916","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110992916?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:01","pubTimestamp":1776261692,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. 宣布，基于2026年第二季度举行的战略会议成果，公司计划向美国食品药品监督管理局（FDA）提交一份修订版的Q-Submission申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614642908","title":"Nexalin Technology, Inc.盘中异动 股价大跌5.94%报0.491美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614642908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614642908?lang=zh_cn&edition=full","pubTime":"2026-02-28 03:16","pubTimestamp":1772219804,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日03时16分，Nexalin Technology, Inc.股票出现波动，股价大幅下挫5.94%。截至发稿，该股报0.491美元/股，成交量5.7425万股，换手率0.31%，振幅7.66%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为0.14%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228031644a727d036&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228031644a727d036&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614176742","title":"Nexalin Technology, Inc.盘中异动 早盘快速上涨18.37%报0.580美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614176742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614176742?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:32","pubTimestamp":1771943537,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时32分，Nexalin Technology, Inc.股票出现异动，股价急速拉升18.37%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为0.63%。其相关个股中，Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 、Nexalin Technology, Inc.、Elutia, Inc.涨幅较大，Allurion Technologies, Inc.、Intelligent Bio Solutions Inc.、Nexalin Technology, Inc.较为活跃，换手率分别为36.40%、3.40%、3.14%，振幅较大的相关个股有Elutia, Inc.、拜尔德医疗、Lifeward Ltd.，振幅分别为16.07%、8.24%、7.83%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224223218a4c36b7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224223218a4c36b7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166639172","title":"Nexalin宣布启动关键性Halo™ Clarity试验，拟通过De Novo途径进军百亿美元失眠市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1166639172","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166639172?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:10","pubTimestamp":1771938607,"startTime":"0","endTime":"0","summary":"Nexalin Technology, Inc.正式披露将开展具有里程碑意义的Halo™ Clarity临床试验。该试验旨在为计划中的De Novo美国食品药品监督管理局（FDA）申请提供关键数据支持，目标直指全球规模达数百亿美元的失眠治疗市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613245278","title":"Nexalin Technology, Inc.盘中异动 股价大涨8.98%报0.500美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613245278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613245278?lang=zh_cn&edition=full","pubTime":"2026-02-20 23:48","pubTimestamp":1771602537,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日23时48分，Nexalin Technology, Inc.股票出现异动，股价快速上涨8.98%。截至发稿，该股报0.500美元/股，成交量5.4924万股，换手率0.29%，振幅4.34%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体涨幅为0.09%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022023485797a695c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022023485797a695c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612267884","title":"Nexalin Technology, Inc.盘中异动 早盘快速拉升5.74%报0.452美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612267884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612267884?lang=zh_cn&edition=full","pubTime":"2026-02-19 23:09","pubTimestamp":1771513795,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日23时09分，Nexalin Technology, Inc.股票出现波动，股价大幅上涨5.74%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为0.71%。其相关个股中，拜尔德医疗、Integer Holdings Corporation、Adagio Medical Holdings, Inc涨幅较大，Profusa, Inc.、Bluejay Diagnostics, Inc.、Envue Medical, Inc.较为活跃，换手率分别为39.51%、21.33%、12.03%，振幅较大的相关个股有Strata Skin Sciences, Inc.、拜尔德医疗、Profusa, Inc.，振幅分别为33.72%、31.16%、14.12%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219230955954178bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219230955954178bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611136178","title":"Nexalin Technology, Inc.盘中异动 大幅跳水5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611136178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611136178?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:04","pubTimestamp":1770915866,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日01时04分，Nexalin Technology, Inc.股票出现异动，股价快速下挫5.45%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体涨幅为0.06%。其相关个股中，Novocure Limited、Ss Innovations International Inc.、Envue Medical, Inc.涨幅较大，Envue Medical, Inc.、Catheter Precision, Inc.、Strata Skin Sciences, Inc.较为活跃，换手率分别为98.27%、88.12%、46.96%，振幅较大的相关个股有Picard Medical, Inc.、Catheter Precision, Inc.、Ss Innovations International Inc.，振幅分别为74.53%、33.16%、25.15%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213010427a49d45fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213010427a49d45fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120077315","title":"Nexalin Technology, Inc.计划将FDA Q-Sub会议的反馈纳入其最终试点研究方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1120077315","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120077315?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:02","pubTimestamp":1764766935,"startTime":"0","endTime":"0","summary":"Nexalin Technology, Inc.计划将FDA Q-Sub会议的反馈纳入其最终试点研究方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149200577","title":"Nexalin Technology完成FDA Q提交会议，针对第二代Sync™神经刺激控制台在阿尔茨海默病项目中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1149200577","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149200577?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:01","pubTimestamp":1764766894,"startTime":"0","endTime":"0","summary":"Nexalin Technology完成FDA Q提交会议，针对第二代Sync™神经刺激控制台在阿尔茨海默病项目中的应用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113861347","title":"Nexalin Technology的Gen-2 Sync药品提交获得美国FDA批准用于阿尔茨海默病和痴呆症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1113861347","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113861347?lang=zh_cn&edition=full","pubTime":"2025-11-05 21:32","pubTimestamp":1762349528,"startTime":"0","endTime":"0","summary":"Nexalin Technology的Q提交已被美国FDA接受，用于Gen-2 Sync治疗阿尔茨海默病和痴呆症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148556630","title":"Nexalin Technology获准在以色列销售Gen 2 Sync、15 Ma Neurostimulation Difs™设备","url":"https://stock-news.laohu8.com/highlight/detail?id=1148556630","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148556630?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:30","pubTimestamp":1761827433,"startTime":"0","endTime":"0","summary":"Nexalin Technology获准在以色列销售Gen 2 Sync、15 Ma Neurostimulation Difs™设备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147822250","title":"Nexalin的Difs™ 神经刺激在三项同行评审研究中显示出阿尔茨海默症和痴呆症患者的认知和大脑网络改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1147822250","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147822250?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:03","pubTimestamp":1761051791,"startTime":"0","endTime":"0","summary":"Nexalin的Difs™ 神经刺激在三项同行评审研究中显示出阿尔茨海默症和痴呆症患者的认知和大脑网络改善","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518638278","title":"Nexalin Technology, Inc.盘中异动 早盘股价大跌5.04%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518638278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518638278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615841,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，Nexalin Technology, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报2.26美元/股，成交量9307股，换手率0.07%，振幅6.98%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为1.28%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104198a2a73b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104198a2a73b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517945791","title":"Nexalin Technology, Inc.盘中异动 下午盘急速下跌5.35%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517945791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517945791?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:10","pubTimestamp":1741288244,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时10分，Nexalin Technology, Inc.股票出现异动，股价大幅跳水5.35%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为2.39%。其相关个股中，Ainos Inc C/Wts 29/07/2027 、Xylo Technologies Ltd、Volitionrx Limited涨幅较大，古特拉、Reshape Lifesciences, Inc.、908 Devices Inc.较为活跃，换手率分别为213.93%、14.73%、9.01%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、古特拉、908 Devices Inc.，振幅分别为40.00%、36.10%、27.00%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031045963c7d6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031045963c7d6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516603853","title":"Nexalin Technology, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516603853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516603853?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:23","pubTimestamp":1741101837,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时23分，Nexalin Technology, Inc.股票出现异动，股价快速下挫5.35%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为0.95%。其相关个股中，908 Devices Inc.、Nexalin Technology Inc C/Wts 、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，908 Devices Inc.、Reshape Lifesciences, Inc.、Venus Concept Inc.较为活跃，换手率分别为130.81%、11.90%、9.35%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、908 Devices Inc.、Venus Concept Inc.，振幅分别为70.05%、35.35%、23.97%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232357989bbac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232357989bbac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630512","title":"Nexalin Technology, Inc.盘中异动 快速跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630512?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:21","pubTimestamp":1741015274,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时21分，Nexalin Technology, Inc.股票出现异动，股价大幅下跌5.17%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体涨幅为1.05%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、飞天兆业、Adagio Medical Holdings, Inc涨幅较大，Reshape Lifesciences, Inc.、Tivic Health Systems, Inc.、Sintx Technologies, Inc.较为活跃，换手率分别为7.07%、6.72%、4.37%，振幅较大的相关个股有Adagio Medical Holdings, Inc、Venus Concept Inc.、Biosig Technologies, Inc.，振幅分别为17.39%、15.78%、14.90%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303232114a25d4f13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303232114a25d4f13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514076320","title":"Nexalin Technology, Inc.盘中异动 早盘股价大跌5.55%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514076320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514076320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Nexalin Technology, Inc.股票出现异动，股价急速下挫5.55%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体涨幅为0.60%。其相关个股中，Monogram Technologies Inc.、Intelligent Bio Solutions Inc.、沃氪医疗涨幅较大，Rapid Micro Biosystems, Inc.、Dih Holding Us, Inc.、沃氪医疗较为活跃，换手率分别为14.99%、3.98%、2.37%，振幅较大的相关个股有Envveno Medical Corporation、Butterfly Network, Inc.、Ainos, Inc.，振幅分别为16.15%、10.19%、8.94%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223435abe0eb87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223435abe0eb87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514862213","title":"Nexalin Technology, Inc.盘中异动 早盘股价大跌6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862213?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:56","pubTimestamp":1740668177,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时56分，Nexalin Technology, Inc.股票出现波动，股价大幅跳水6.32%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体涨幅为0.10%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Lensar, Inc.、Biomerica, Inc.涨幅较大，Sintx Technologies, Inc.、Tandem Diabetes Care, Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为4.29%、4.02%、3.97%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Dih Holdings Us Inc C/Wts 20/04/2028 、Beyond Air, Inc.，振幅分别为41.21%、26.67%、17.88%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225617abdf74ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225617abdf74ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514561158","title":"Nexalin Technology, Inc.盘中异动 早盘股价大涨10.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514561158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514561158?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:30","pubTimestamp":1740580258,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时30分，Nexalin Technology, Inc.股票出现波动，股价急速拉升10.00%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Inogen, Inc、飞天兆业、拜尔德医疗涨幅较大，Biomerica, Inc.、Venus Concept Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为8.99%、8.06%、5.02%，振幅较大的相关个股有Owlet, Inc.、Vicarious Surgical Inc.、Cytek Biosciences, Inc.，振幅分别为3.94%、3.07%、2.34%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223059abddec5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223059abddec5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514153000","title":"Nexalin Technology, Inc.盘中异动 急速下跌5.32%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514153000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514153000?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:15","pubTimestamp":1740496503,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时15分，Nexalin Technology, Inc.股票出现异动，股价大幅下挫5.32%。Nexalin Technology, Inc.股票所在的医疗器械行业中，整体跌幅为0.38%。其相关个股中，Adapthealth Corp.、Biosig Technologies, Inc.、Anteris Technologies Global Corp.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Nano-X Imaging Ltd较为活跃，换手率分别为38.26%、5.65%、3.48%，振幅较大的相关个股有Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Pavmed Inc C/Wts 30/04/2025 Class Z、Biosig Technologies, Inc.，振幅分别为125.32%、35.71%、31.19%。Nexalin Technology, Inc.公司简介：Nexalin Technology Inc设计和开发创新的神经刺激产品，独特且有效地帮助对抗正在进行的全球精神健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231503abdc8929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231503abdc8929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nexalin.com","stockEarnings":[{"period":"1week","weight":0.4543},{"period":"1month","weight":0.2515},{"period":"3month","weight":-0.2623},{"period":"6month","weight":-0.6651},{"period":"1year","weight":-0.7058},{"period":"ytd","weight":-0.0878}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nexalin Technology, Inc.于2010年10月19日成立为内华达州公司。2021年12月1日，公司成为新成立的特拉华州公司。该公司设计和开发创新的神经刺激产品，以独特和有效的方式帮助对抗持续的全球心理健康流行病。该公司开发了一种易于管理的医疗设备——被称为“Generation 1”或“Gen-1”——利用生物电子医疗技术治疗焦虑和失眠，无需药物或心理治疗。该公司最初的Gen-1设备是颅电疗法刺激（CES）设备，在治疗期间以4毫安的速度发射波形，目前被美国食品药品监督管理局（“FDA”）归类为II类设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.089768},{"month":2,"riseRate":0,"avgChangeRate":-0.130321},{"month":3,"riseRate":0.25,"avgChangeRate":0.7182},{"month":4,"riseRate":0.75,"avgChangeRate":0.128112},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.27991},{"month":6,"riseRate":0.666667,"avgChangeRate":0.427813},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.133577},{"month":8,"riseRate":0,"avgChangeRate":-0.230902},{"month":9,"riseRate":0,"avgChangeRate":-0.109096},{"month":10,"riseRate":0.75,"avgChangeRate":0.844573},{"month":11,"riseRate":0.75,"avgChangeRate":0.333914},{"month":12,"riseRate":0.25,"avgChangeRate":-0.366317}],"exchange":"NASDAQ","name":"Nexalin Technology, Inc.","nameEN":"Nexalin Technology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nexalin Technology, Inc.(NXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nexalin Technology, Inc.(NXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nexalin Technology, Inc.,NXL,Nexalin Technology, Inc.股票,Nexalin Technology, Inc.股票老虎,Nexalin Technology, Inc.股票老虎国际,Nexalin Technology, Inc.行情,Nexalin Technology, Inc.股票行情,Nexalin Technology, Inc.股价,Nexalin Technology, Inc.股市,Nexalin Technology, Inc.股票价格,Nexalin Technology, Inc.股票交易,Nexalin Technology, Inc.股票购买,Nexalin Technology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nexalin Technology, Inc.(NXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nexalin Technology, Inc.(NXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}